Procter & Gamble: Global Disinflation, Productivity Justify Current Share Price With Potential Further Upside

Summary:

  • For 1Q25, PG generated $21.7 billion in revenue, declining by 0.61% year-on-year and missing estimates by $239.84 million. Net margin deteriorated to 18.22% from 20.67% due to higher non-operating expenses.
  • Despite a poor consumer environment, organic sales surged by 2%. Recent trends in disinflation and strength in retail sales will continue to serve as tailwinds, supporting demand for PG’s products.
  • Other factors such as productivity gains, weakening dollar, and growth in under-represented markets will provide PG with more opportunities to enhance the company’s bottom line.
  • Valuation analysis suggests that further upside potential exists. DCF based valuation model suggest a potential upside of at least 18%.

Logo of Procter and Gamble.

RobsonPL

Introduction

Protect & Gamble (NYSE:PG) is on the world’s largest consumer goods companies and owns iconic household brands such as Gillette, Oral B, Pantene, Vicks and more. The company currently has more than 107k full-time employees and sells their products to


Analyst’s Disclosure: I/we have no stock, option or similar derivative position in any of the companies mentioned, but may initiate a beneficial Long position through a purchase of the stock, or the purchase of call options or similar derivatives in PG over the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.

Seeking Alpha’s Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.


Leave a Reply

Your email address will not be published. Required fields are marked *